[information webinar] BioWin R&I competitiveness calls
Testimonials and Q&A
[information webinar] BioWin R&I competitiveness calls
Tickets
[information webinar] BioWin R&I competitiveness calls
Testimonials and Q&A
Are you seeking funding to launch an innovative and collaborative research project in biopharmacy, biotechnology, medtech, or ehealth? Attend this information session on November 30th from 4.30 PM to 5.30 PM to find out everything you need to know about BioWin R&I project calls.
Join us to hear from our R&I team and three successful applicants about BioWin competitiveness cluster project opportunities. We will discuss (1) what these project calls aim to achieve, (2) who can apply, (3) how to put together your proposal, (4) the timeline, and (5) the help BioWin provides. Following this presentation, you will hear from three project leaders on their journey, results, and teamwork with BioWin.
Objectives:
- Identify funding opportunities available through competitive cluster calls for projects in biopharmacy, biotechnology, medtech, or ehealth.
- Understand the eligibility criteria, application preparation process, and call schedules.
- Explore the support services provided by BioWin.
- Hear testimonials from 3 project leaders that were awarded the label
You will hear from:
- Marianne Ghyoot, Director Research & Innovation, BioWin
- Thierry Ferain, Director Innovation & Growth, BioWin
- Loïc Germain, Senior Innovation Manager, BioWin
- Aloys du Bois d’Aische, Co-Founder, Eonix
- Hara Episkopou, Head of Discovery, Novadip Biosciences
- Pierre Martinot, Co-Founder & CTO, Sunrise
- Cécile Roy, Head of Operations, Sunrise
Agenda:
16h30 – 16h45: Information on BioWin competitive cluster calls. We will present (i) the objectives of competitive cluster calls, (ii) the eligibility criteria, (iii) the application process, (iv) the timeline, and (v) the support offered by BioWin.
Marianne Ghyoot, Thierry Ferain, Loïc Germain
16h45 – 17h15: Testimonials from 3 successful applicants. Testimonials from 3 project leaders, including one recently labeled (Gloria, Eonix), one at the midway point (Theramir, Novadip Biosciences), and one with a success story conclusion (eLISA, Sunrise).
Aloys du Bois d’Aische (Eonix), Hara Episkopou (Novadip Biosciences), Pierre Martinot and Cécile Roy (Sunrise)
17h15 – 17h30: Q&A Session. We will address all your questions related to competitive cluster project calls and the application process.
Marianne Ghyoot, Thierry Ferain, Loïc Germain
Language: French (English for one testimonial)